AAPH |
2,2′-azo-bis-(2-methylpropionamidine) dihydrochloride |
ABC |
ATP binding cassette |
ADR |
Adriamycin, trade name of doxorubicin |
BCRP |
breast cancer resistance protein |
BHA |
butylated hydroxyanisole |
BHT |
butylhydroxytoluen |
CAA |
cellular antioxidant activity |
COX-2 |
cyclooxygenase-2 |
DCFH-DA |
2′,7′-dichlorofluorescin diacetate |
DPPH |
2,2-diphenyl-1-picrylhydrazyl |
DMEM |
Dulbecco’s Modified Eagle’s Medium - high glucose |
EMEM |
Eagle´s Minimum Essential Medium |
FBS |
fetal bovine serum |
FCR |
Folin–Ciocalteu reagent |
FRAP |
ferric reducing ability of plasma |
HepG2 |
human hepatocellular adenocarcinoma |
HOC |
human ovarian adenocarcinoma |
HOC/ADR |
human ovarian adenocarcinoma resistant to doxorubicin |
IL-1 |
Interleukin-1 |
iNOS |
inducible isoform of nitric oxide synthases |
LPS |
lipopolysaccharides |
LOX |
lipoxygenase |
MDR |
multidrug resistance |
MEM |
Essential Medium Eagle no phenol red |
NF-κB |
nuclear factor kappa-light-chain-enhancer of activated B cells |
ORAC |
oxygen radical absorption capacity |
P-gp |
P-glycoprotein |
PBS |
Phosphate-buffered saline |
RAW 264.7 |
mouse macrophages |
RLU |
relative luminescence units |
THTT |
thyroid hormone transmembrane transporters |
TNF-α |
tumor necrosis factor alpha |